Algert Global’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
Algert Global's RGEN Position: Q4 2025 in Review
Algert Global sold out of Repligen (RGEN) in Q4 2025, closing a stake of 9,530 shares — an estimated $1.27M sold.
Algert Global first reported a position in RGEN in Q2 2013 and held it in 18 quarters. The position peaked at $3.88M in Q3 2022. 474 funds tracked by Wall St. Rank hold RGEN as of Q4 2025.
- Algert Global reported no remaining Repligen position as of Q4 2025 after selling out during the quarter.
- Algert Global sold 9,530 Repligen shares in Q4 2025, an estimated $1.27M.
- Algert Global first reported a position in Repligen in Q2 2013 and held it in 18 quarters.
- Algert Global's Repligen position peaked at $3.88M in Q3 2022.
- 474 funds tracked by Wall St. Rank held Repligen as of Q4 2025.
Based on Algert Global's 13F filing for Q4 2025, filed 17 Feb 2026.